Reversal of Antipsychotic-Induced Hyperprolactinemia, Weight Gain, Hyperglycemia and Dyslipidemia

NCT00541554 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

INDUSTRY

Sponsor class

Conditions

Hyperprolactinemia
Weight Gain
Dyslipidemia

Interventions

DRUG: Abilify (aripiprazole)

Sponsor

Genovate Biotechnology Co., Ltd.,